Hunault-Berger, M <br/><br/>
Maintenance therapy with alternating azacitidine and lenalidomide in elderly fit patients with poor prognosis acute myeloid leukemia: a phase II multicentre FILO trial.  [electronic resource] 

 -  Blood cancer journal  06 2017 
 - e568 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2044-5385 
<br/><br/><label>Standard No.: </label>10.1038/bcj.2017.50  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Azacitidine--administration & dosage<br/>Disease-Free Survival<br/>Female<br/>Humans<br/>Lenalidomide<br/>Leukemia, Myeloid, Acute--drug therapy<br/>Maintenance Chemotherapy<br/>Male<br/>Middle Aged<br/>Survival Rate<br/>Thalidomide--administration & dosage